ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

Liu Guanglin; Zheng Haiqing; Zhang Zhibing; Wu Zhiqiang; Xiong Huaping; Li Jun; Song Libing*中山大学
BMC Cancer2010-9-16DOI: 10.1186/1471-2407-10-495
22被引4阅读
引用收藏
分享

摘要

Background: Overexpression of sphingosine kinase-1 (SPHK1) has been demonstrated to be associated with the development and progression in various types of human cancers. The current study was to characterize the expression of SPHK1 in salivary gland carcinomas (SGC) and to investigate the association between SPHK1 expression and progression of SGC. <br>Methods: The expression of SPHK1 was examined in 2 normal salivary gland tissues, 8 SGC tissues of various clinical stages, and 5 pairs of primary SGC and adjacent salivary gland tissues from the same patient, using real-time PCR and western blot analysis. Furthermore, the SPHK1 protein expression was analyzed in 159 clinicopathologically characterized SGC cases by immunohistochemistry. Statistical analyses were performed to determine the prognostic and diagnostic associations. <br>Results: SPHK1 expression was found to be markedly upregulated in SGC tissues than that in the normal salivary gland tissues and paired adjacent salivary gland tissues, at both mRNA and protein levels. Statistical analysis revealed a significant correlation of SPHK1 expression with the clinical stage (P = 0.005), T classification (P = 0.017), N classification (P = 0.009), M classification (P = 0.002), and pathological differentiation (P = 0.013). Patients with higher SPHK1 expression had shorter overall survival time, whereas patients with lower SPHK1 expression had better survival. Importantly, patients in the group without adjuvant therapy who exhibited high SPHK1 expression had significantly lower overall survival rates compared with those with low SPHK1 expression. Moreover, multivariate analysis suggested that SPHK1 expression might be an independent prognostic indicator for the survival of SGC patients. <br>Conclusions: Our results suggest that SPHK1 expression is associated with SGC progression, and might represent as a novel and valuable predictor for adjuvant therapy to SGC patients.

相关
加载中…
  • Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival
    Li Jun; Guan Hong Yu; Gong Li Yun; Song Li Bing; Zhang Nu; Wu Jueheng; Yuan Jie; Zheng Yi Jie; Huang Zheng Song; Li Mengfeng*Clinical Cancer Research, 2008, 14(21): 6996-7003.被引 75
  • Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma
    Bao, Ji-Ming*; Zhi, Xi; Yuan, Hao-Yu; Chen, Tao-Yi; Chen, Ming-Kun; Zhou, Jun-Hao; Xue, Kang-Yi; Yang, Jian-Kun*; Liu, Cun-Dong*Translational Cancer Research, 2023, 12(3): 572-584.
  • Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform
    Chen, Hongjie; Haddadi, Nahal; Zhu, Xiaofeng; Hatoum, Diana; Chen, Size; Nassif, Najah T.; Lin, Yiguang*; McGowan, Eileen M.*Journal of Oncology, 2022, 2022: 2250407.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Cancer
发表日期
2010-09-16
卷期
第 10 卷
页码
495
DOI
10.1186/1471-2407-10-495
语言
ENGLISH
成果收录
SCI
资助标注
Foundation of Ministry of Science and Technology of China [81071780, 81030048, 30770836, 30771110, 30870963, 30831160517, 30900547]; Program for New Century Excellent Talents in University [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [8251008901000006, 2008A030201006]; Foundation of Ministry of Education [(2008)890, 200805580047]; Fundamental Research Funds for the Central Universities [10ykzd03]

作者

  • L

    Liu Guanglin (第一作者)

  • Z

    Zheng Haiqing

查看全部 7 位作者收起作者
  • Z

    Zhang Zhibing

  • W

    Wu Zhiqiang

  • X

    Xiong Huaping

  • L

    Li Jun

  • S

    Song Libing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417